Christoph Brackmann's most recent trade in NovoCure Ltd was a trade of 7,033 Ordinary Shares done at an average price of $12.2 . Disclosure was reported to the exchange on Nov. 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NovoCure Ltd | Christoph Brackmann | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.23 per share. | 04 Nov 2025 | 7,033 | 134,117 (0%) | 0% | 12.2 | 86,014 | Ordinary Shares |
| NovoCure Ltd | Christoph Brackmann | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 11.63 per share. | 29 Jul 2025 | 10,000 | 131,150 (0%) | 0% | 11.6 | 116,300 | Ordinary Shares |
| NovoCure Ltd | Christoph Brackmann | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 11.50 per share. | 29 Jul 2025 | 5,000 | 141,150 (0%) | 0% | 11.5 | 57,500 | Ordinary Shares |
| NovoCure Ltd | Christoph Brackmann | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 11.60 per share. | 29 Jul 2025 | 5,000 | 136,150 (0%) | 0% | 11.6 | 58,000 | Ordinary Shares |
| NovoCure Ltd | Christoph Brackmann | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 81,499 | 81,499 | - | - | Stock Options (Right to buy) | |
| NovoCure Ltd | Christoph Brackmann | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 18.19 per share. | 04 Mar 2025 | 54,975 | 121,150 (0%) | 0% | 18.2 | 999,995 | Ordinary Shares |